Clinical trials
catalyst calendar across sponsors →Studies where PSNL is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 observational
Held by 12 tracked-famous managers (JANE STREET GROUP, LLC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, +7 more) · FINRA short interest 1.7 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 7 sells · government filings 180d: none disclosed
| Study | Phase | Status | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|
| CtDNA Based MRD Testing for NAC Monitoring in TNBCNCT06230185observationalEvaluate the correlation of MRD to pCR after NAC in TNBC | — | Recruiting | TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease | 422 | 2025-08-30 | 2025-01-07 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19